Riskpilot← Back to searchSign inGet full accessD.Chantzichristos AB
ABActiveOrg 5592430010Engelbrektsgatan 12Medical specialists activities · NACE 8622Est. 20200 employees
Revenue 2025
SEK 4K
-95% vs 2024
EBITDA margin
-830.6%
-168% vs 2024
Equity ratio
82.8%
Financial strength
Net profit 2025
SEK 16K
-51% vs 2024
| Revenue | SEK 4K | -95% |
| EBITDA | SEK -37K | -168% |
| Net profit | SEK 16K | -51% |
| Total assets | SEK 96K | -34% |
| Equity | SEK 79K | +25% |
| Employees | 0 | — |
Legal name
D.Chantzichristos AB
Org number
5592430010
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
18 februari 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva medicinsk konsultverksamhet: specialistläkarverksamhet inom öppenvård, specialistutbildningar, föreläsningar, skrivande av medicinska artiklar samt bedriva därmed förenlig verksamhet. Bolaget ska också äga och förvalta värdepapper och fastigheter.
Address
Engelbrektsgatan 12
Email
dim_chchristos@yahoo.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 103 | 123 | 65 | 96 | 4 |
| Staff expenses | — | −1 | −0 | −1 | −0 |
| EBITDA | 60 | 92 | 14 | 54 | −37 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 60 | 92 | 14 | 54 | −37 |
| Net financials | — | 0 | 1 | 2 | 0 |
| Profit before tax | 42 | 69 | 16 | 41 | 21 |
| Tax | −12 | −15 | −4 | −9 | −5 |
| Net profit | 30 | 54 | 12 | 32 | 16 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 113 | 204 | 199 | 145 | 96 |
| Equity | 86 | 140 | 152 | 63 | 79 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 9 | 22 | 5 | 24 | 16 |
| Total debt | 9 | 22 | 5 | 24 | 16 |
EBITDA margin
-830.6%
This company
15.8%
Market median
-5357% vs market
20212025
Equity ratio
82.8%
This company
38.2%
Market median
+117% vs market
20212025
Return on equity
19.8%
This company
18.4%
Market median
+8% vs market
20212025
Net profit margin
355.4%
This company
8.1%
Market median
+4288% vs market
20212025
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20212025
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of D.Chantzichristos AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Michael | Deputy Board Member | 0 companies |
| Dimitrios Chantzichristos | Board of Directors | 0 companies |